BioRestorative Therapies, Inc. (BRTX)
0.2132
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.2158
0.00 (0.00%)
After-Hours: 20:00
BioRestorative Therapies Shareholders Equity (Quarterly) : 3.026M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.026M |
| December 31, 2025 | 0.3567M |
| September 30, 2025 | 2.207M |
| June 30, 2025 | 4.845M |
| March 31, 2025 | 6.145M |
| December 31, 2024 | 8.531M |
| September 30, 2024 | 9.992M |
| June 30, 2024 | 10.80M |
| March 31, 2024 | 14.50M |
| December 31, 2023 | 10.00M |
| September 30, 2023 | 12.83M |
| June 30, 2023 | 12.40M |
| March 31, 2023 | 13.49M |
| December 31, 2022 | 15.83M |
| September 30, 2022 | 17.00M |
| June 30, 2022 | 18.59M |
| March 31, 2022 | 20.16M |
| December 31, 2021 | 21.60M |
| September 30, 2021 | -4.879M |
| June 30, 2021 | -3.809M |
| March 31, 2021 | -2.694M |
| December 31, 2020 | -1.332M |
| September 30, 2020 | -15.09M |
| June 30, 2020 | -14.44M |
| March 31, 2020 | -17.54M |
| Date | Value |
|---|---|
| December 31, 2019 | -12.78M |
| September 30, 2019 | -12.43M |
| June 30, 2019 | -8.942M |
| March 31, 2019 | -7.653M |
| December 31, 2018 | -8.641M |
| September 30, 2018 | -8.938M |
| June 30, 2018 | -9.868M |
| March 31, 2018 | -7.690M |
| December 31, 2017 | -6.837M |
| September 30, 2017 | -6.690M |
| June 30, 2017 | -5.715M |
| March 31, 2017 | -4.722M |
| December 31, 2016 | -5.000M |
| September 30, 2016 | -4.471M |
| June 30, 2016 | -4.005M |
| March 31, 2016 | -3.541M |
| December 31, 2015 | -3.908M |
| September 30, 2015 | -3.776M |
| June 30, 2015 | -2.880M |
| March 31, 2015 | -7.395M |
| December 31, 2014 | -6.888M |
| September 30, 2014 | -6.458M |
| June 30, 2014 | -7.149M |
| March 31, 2014 | -6.983M |
| December 31, 2013 | -6.685M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 303.90M |
| CareDx, Inc. | 425.60M |
| Natera, Inc. | 1.821B |
| Exagen, Inc. | 12.22M |
| Sera Prognostics, Inc. | 59.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.640M |
| Total Liabilities (Quarterly) | 1.615M |
| Debt to Equity Ratio | 0.0114 |
| Current Ratio | 2.353 |
| Net Debt Paydown Yield | -0.10% |